MedicarePartD.guide

A non-government resource built from CMS public data

Aimovig on SilverScript Choice (S5601-004)

erenumab

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 1 per 30 days.

$149.90
Patient pays / month, after deductible
$648.05
Patient pays / month, before the $615.00 deductible
$449.70
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

AIMOVIG 70 mg/mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $788.95 for a month. Other covered strengths are listed below.

Prior authRequired on all 2 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 2 covered strengths and forms
FormTierPatient pays / monthLimits
AIMOVIG 70 mg/mL Injection3$149.90PA · 1 per 30 days
AIMOVIG 140 mg/mL Injection, Solution3$149.95PA · 1 per 30 days

Other CGRP migraine drugs on this plan

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-004